Company: LBRX
Filing Date: 2025-07-23
Form Type: DRS/A
Source: 0000950123-25-006557
Chunk: 327

Company: LB PHARMACEUTICALS INC
Filing Date: 2025-07-23
Form: DRS/A
Chunk 327
---
isable for common stock. They also apply to common stock owned now or acquired later by the person executing the lock-upagreement or for which the person executing the lock-upagreement later acquires the power of disposition. Nasdaq Global Market Listing We have applied to list our common stock on the Nasdaq Global Market, subject to notice of issuance, under the symbol “LBRX.” Determination of Offering Price Prior to this offering, there has been no public market for our common stock. The initial public offering price for our common stock will be determined through negotiations between us and the representatives. In addition to prevailing market conditions, the factors to be considered in determining the initial public offering price are:

| • |     | the valuation multiples of publicly traded companies that the representatives believe to be comparable to us; |

| • |     | our financial information; |

| • |     | the history of, and the prospects for, our company and the industry in which we compete; |

| • |     | an assessment of our management, its past and present operations, and the prospects for, and timing of, our 
 future revenues;                                                                                            |

225

| • |     | the present state of our development; and |

| • |     | the above factors in relation to market values and various valuation measures of other companies engaged in 
 activities similar to ours.                                                                                 |

An active trading market for the shares may not develop. It is also possible that after this offering, our common stock will not trade in the public market at or above the initial public offering price. The underwriters do not expect to sell more than 5% of the shares in the aggregate to accounts over which they exercise discretionary authority. Price Stabilization, Short Positions and Penalty Bids Until the distribution of the shares is completed, SEC rules may limit underwriters and selling group members from bidding for and purchasing our common stock. However, the representatives may engage in transactions that stabilize the price of the common stock, such as bids or purchases to peg, fix or maintain that price. In connection with this offering, the underwriters may purchase and sell our common stock in the open market. These transactions may include short sales, purchases on the open market to cover positions created by short sales and stabilizing transactions. Short sales involve the sale by the underwriters of a greater number of shares than they are required to purchase in this offering. “Covered” short sales are sales made in an amount not greater than the underwriters’ over-allotment option described above. The